Bart G - Search Results

1

Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene.

Bart G, LaForge KS, Borg L, Lilly C, Ho A, Kreek MJ. Bart G, et al. Neuropsychopharmacology. 2006 Oct;31(10):2313-7. doi: 10.1038/sj.npp.1301128. Epub 2006 Jun 21. Neuropsychopharmacology. 2006. PMID: 16794569 Clinical Trial.

2

Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.

Schluger JH, Bart G, Green M, Ho A, Kreek MJ. Schluger JH, et al. Among authors: bart g. Neuropsychopharmacology. 2003 May;28(5):985-94. doi: 10.1038/sj.npp.1300156. Epub 2003 Mar 26. Neuropsychopharmacology. 2003. PMID: 12700714

3

Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.

Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L, Heilig M. Bart G, et al. Neuropsychopharmacology. 2005 Feb;30(2):417-22. doi: 10.1038/sj.npp.1300598. Neuropsychopharmacology. 2005. PMID: 15525999

4

Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?

Bart G, Schluger JH, Borg L, Ho A, Bidlack JM, Kreek MJ. Bart G, et al. Neuropsychopharmacology. 2005 Dec;30(12):2254-62. doi: 10.1038/sj.npp.1300811. Neuropsychopharmacology. 2005. PMID: 15988468

5

Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone.

Ducat E, Ray B, Bart G, Umemura Y, Varon J, Ho A, Kreek MJ. Ducat E, et al. Among authors: bart g. Addict Biol. 2013 Mar;18(2):325-31. doi: 10.1111/j.1369-1600.2011.00313.x. Epub 2011 Apr 20. Addict Biol. 2013. PMID: 21507151 Free PMC article.

6

Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects.

Bart G, Borg L, Schluger JH, Green M, Ho A, Kreek MJ. Bart G, et al. J Pharmacol Exp Ther. 2003 Aug;306(2):581-7. doi: 10.1124/jpet.103.050682. Epub 2003 May 2. J Pharmacol Exp Ther. 2003. PMID: 12730354 Clinical Trial.

7

Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA.

Kreek MJ, Schlussman SD, Bart G, Laforge KS, Butelman ER. Kreek MJ, et al. Among authors: bart g. Neuropharmacology. 2004;47 Suppl 1:324-44. doi: 10.1016/j.neuropharm.2004.07.024. Neuropharmacology. 2004. PMID: 15464148 Review.

8

Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.

Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA. Kreek MJ, et al. Among authors: bart g. Pharmacol Rev. 2005 Mar;57(1):1-26. doi: 10.1124/pr.57.1.1. Pharmacol Rev. 2005. PMID: 15734726 Review.

9

Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence.

Williams TJ, LaForge KS, Gordon D, Bart G, Kellogg S, Ott J, Kreek MJ. Williams TJ, et al. Among authors: bart g. Addict Biol. 2007 Sep;12(3-4):496-502. doi: 10.1111/j.1369-1600.2007.00069.x. Epub 2007 Jun 8. Addict Biol. 2007. PMID: 17559549

10

Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.

Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, Kreek MJ. Bart G, et al. Mol Psychiatry. 2004 Jun;9(6):547-9. doi: 10.1038/sj.mp.4001504. Mol Psychiatry. 2004. PMID: 15037869 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters